Status:
UNKNOWN
Effect of Inhaled Hydroxy Gas on Long COVID Symptoms
Lead Sponsor:
Oxford Brookes University
Conditions:
Post-Acute COVID-19 Syndrome
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
The goal of this clinical trial is to see if several weeks of self-administered, home-based, treatment involving breathing hydroxy gas (a mixture of hydrogen and oxygen) for at least 2 hours a day for...
Eligibility Criteria
Inclusion
- Any moderate or severe pain, breathlessness, or fatigue associated with long COVID
- live within an hour's drive of the Oxford Brookes campus
Exclusion
- Pre-existing secondary diseases; tumors, mental health conditions, chronic respiratory conditions such as Chronic Obstructive Pulmonary Disease (COPD), and cardiac disease
- Previous requirement of ICU treatment due to COVID
- Acute or chronic infections or no pre-existing autoimmune diseases
Key Trial Info
Start Date :
September 25 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 31 2024
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT06159296
Start Date
September 25 2023
End Date
May 31 2024
Last Update
December 6 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Oxford Brookes University
Oxford, Oxfordshire, United Kingdom, OX3 0BP